Cosmetic Animal Testing Bans vs REACH: The 2026 Conflict

TL;DR: Cosmetic animal testing bans are currently being challenged by the EU REACH regulation, which requires new animal data for chemical safety assessments of ingredients already in use. Despite global pledges for cruelty-free beauty, regulatory loopholes now force thousands of animals into new toxicity tests for workers' safety and environmental standards.

In a laboratory just outside Brussels, the year is 2026, and a rabbit is being prepared for a skin irritation test. To a casual observer, this might seem like a relic of the past. After all, the European Union famously banned the testing of finished cosmetic products on animals in 2004, followed by a full marketing ban on animal-tested ingredients in 2013. Yet, this rabbit is a victim of a growing regulatory paradox that has effectively reopened the doors to animal experimentation under the guise of chemical safety.

For consumers in the US, UK, and EU, the "Leaping Bunny" logo was once a guarantee of ethical production. However, a legislative tug-of-war between the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation and the Cosmetics Regulation has created a gray area where "cruelty-free" no longer means "no animal testing was performed."

Understanding Cosmetic Animal Testing Bans and REACH

Cosmetic animal testing bans were designed to ensure that no animal suffers for human vanity, but they are currently being bypassed by REACH requirements that demand animal data for environmental and worker safety. While the Cosmetics Regulation prohibits testing for consumer safety, REACH mandates that chemicals produced in high volumes must be tested for long-term health and ecological impacts, often involving animal models.

This conflict centers on "dual-use" ingredients—substances like salicylic acid or common UV filters that are used in cosmetics but also in other industrial applications. The European Chemicals Agency (ECHA) has increasingly ruled that the animal testing ban only applies to tests performed specifically to prove consumer safety, not to tests required to assess risks to factory workers or the environment.

The Legal Loophole Explored

The fundamental issue is that REACH treats cosmetic ingredients as chemicals first and beauty products second. Under the current 2026 enforcement landscape, if a chemical is suspected of being an endocrine disruptor or an aquatic toxin, ECHA can mandate new vertebrate animal tests, even if that chemical has been used safely in makeup for thirty years.

Bottom line: The 2013 ban promised a cruelty-free market, but REACH has effectively re-introduced animal testing for the majority of cosmetic ingredients.

The Regulatory Roots: Why 2004 and 2013 Were Landmarks

The 2004 and 2013 EU bans were not just political gestures—they were the culmination of decades of advocacy and scientific progress. The 2004 ban on finished products came after public outrage over the Draize test, which involved applying chemicals directly to rabbits' eyes. The 2013 marketing ban went further, prohibiting the sale of any cosmetic ingredient tested on animals anywhere in the world, even if the test was conducted outside the EU. This made the EU a global standard-setter, forcing international brands to align with its ethical standards to access the world's largest beauty market (according to the European Commission, 2023).

However, these bans were never absolute. They contained a built-in caveat: they applied only to testing conducted "for the purposes of" the Cosmetics Regulation. This wording, intended as a pragmatic compromise, left the door open for other regulations to impose animal tests. REACH, which predates the cosmetics ban in its 2006 formulation, was the obvious candidate. As the regulatory framework for all chemicals, REACH requires safety data for substances produced or imported above one tonne per year—and that data has traditionally come from animal studies (ECHA, 2023).

So, while the cosmetics industry celebrated its cruelty-free triumph, the chemicals industry—and by extension, cosmetic ingredient suppliers—continued to submit animal data to REACH. The legal separation was clear on paper but porous in practice.

The Impact of ECHA Rulings on Global Welfare

Recent rulings by the ECHA Board of Appeal have solidified the requirement for new animal tests on ingredients that were previously considered "safe and settled." These rulings have sparked outrage among animal rights organizations and ethical brands who argue that modern, non-animal methods (NAMs) are now sophisticated enough to provide the necessary safety data without resorting to legacy testing protocols.

The most consequential ruling came in 2023, when ECHA's Board of Appeal upheld a decision requiring new animal tests for a UV filter used in sunscreens. The companies argued that the ingredient had been used for decades and was already proven safe for consumers. But ECHA countered that REACH requires full environmental and worker safety data, and the existing data were outdated or incomplete. The board ruled that the cosmetics ban "does not apply to requirements under other legislation," a precedent that has been cited in subsequent decisions (ECHA Board of Appeal, Case A-004-2022). According to Cruelty Free International (2025), this precedent has led to over 100 chemical safety assessments under REACH that now involve requests for new animal testing on ingredients used exclusively or primarily in cosmetics.

Scientists using organ-on-a-chip technology in a modern, animal-free laboratory.

The ramifications extend beyond the EU. The UK's post-Brexit REACH regime, which mirrors the EU's, has adopted similar interpretations. In the US, while state-level bans like California's 2020 Cruelty-Free Cosmetics Act are in place, the federal Humane Cosmetics Act remains stalled in Congress. And in Asia, markets like China have only recently begun lifting mandatory animal testing for certain products, but the REACH-style chemicals law still allows testing for industrial safety (HSI, 2024).

A rescue rabbit in a peaceful sanctuary symbolizing the animals impacted by cosmetic animal testing bans violations.

Key stat: According to Cruelty Free International (2025), over 100 chemical safety assessments under REACH currently involve requests for new animal testing on ingredients used exclusively or primarily in cosmetics.

The Evidence and Numbers: How Many Animals Are Affected?

Exact counts of animals used in such tests are difficult to obtain because REACH does not require reporting by ingredient type or end-use. However, the trends are clear. In 2023, ECHA reported that the number of animal tests proposed in REACH registration dossiers had actually increased since the cosmetics ban, reversing a decade of decline. Specifically, ECHA's database showed a rise in requests for new reproductive toxicity studies (which use rats) and bioaccumulation studies in fish, both driven by REACH compliance (ECHA, 2024).

To extrapolate, a single endocrine-disruptor study can use up to 1,500 rats, while a fish toxicity test may involve 200 fish per dose group. If just 50 ingredients per year are subject to new testing, that translates to tens of thousands of animals annually. The European Coalition to End Animal Experiments (ECEAE, 2025) estimates that 20,000–30,000 animals per year are at risk due to REACH-induced tests on cosmetic ingredients. This is a fraction of the 1.2 million animals used in all EU chemical testing, but it is a significant emotional and ethical setback for the cosmetics industry and its consumers.

Moreover, the numbers are not static. As REACH's registration deadlines for high-volume chemicals approach (EU REACH requires full data for all substances above 1 tonne per year by 2028), the number of cosmetics-related tests is projected to rise. According to ECEAE, by 2027, the figure could double.

Modern Science: Moving Beyond the Draize Test

The argument for continued testing often hinges on the claim that "there are no alternatives." However, the scientific community disagrees. New Approach Methodologies (NAMs) include in vitro (cell-based) assays, in silico (computer modeling), and organ-on-a-chip technologies that often predict human reactions more accurately than rodent or rabbit models.

• 🌱 In Vitro Testing: Human skin cells grown in labs to test for corrosivity.
• 💻 Computer Modeling: AI-driven data that predicts toxicity based on molecular structure.
• 🧬 Genomics: Studying how chemicals affect gene expression in human tissues.
• 💧 Microfluidics: Simulating the movement of chemicals through human organs.

Despite these advancements, regulatory inertia remains high. Regulators are often hesitant to accept NAMs because animal data has been the "gold standard" for decades, even if that standard is scientifically flawed. According to the European Food Safety Authority (EFSA, 2024), animal models can fail to predict human toxicity in up to 30% of cases for certain chemical classes.

For example, the Organisation for Economic Co-operation and Development (OECD) has validated test guidelines for in vitro skin irritation and eye corrosion, and these are now widely used for cosmetics. But for systemic endpoints like reproductive toxicity, NAMs are still not validated at the regulatory level. The OECD is working on a defined approach for skin sensitisation that combines in vitro and in silico data, but adoption is slow.

Part of the problem is a lack of funding and political will to accelerate NAM validation. The EU's Horizon 2020 program funded projects like

ASPIS (Animal-free Safety assessment of chemicals Project Innovation)

to develop NAM batteries, but the full validation process can take a decade (ASPIS Project, 2024). Meanwhile, companies are forced to run legacy animal tests to meet REACH deadlines.

How It Works in Practice: The Journey of a Cosmetic Ingredient

To understand the conflict, it's helpful to walk through the lifecycle of a cosmetic ingredient, from synthesis to market.

1. Chemical synthesis: A company develops a new UV filter. It registers the chemical under REACH, submitting a dossier that includes physicochemical properties and, if required, toxicological data.
2. Initial testing: For the cosmetics application, the company can rely on animal data from existing studies or use NAMs to demonstrate safety. But for REACH, the chemical is classified as a high-volume substance (>100 tonnes/year).
3. REACH requirement: REACH demands full toxicological data for human health (acute toxicity, skin/eye irritation, mutagenicity, reproductive toxicity) and ecotoxicity (fish, daphnia, algae). If the dossier lacks these, ECHA issues a compliance check and requests new tests.
4. The clash: The company protest that the cosmetic ban should preclude new animal tests. ECHA counters that the tests are for worker and environmental safety, not consumer safety. The company must then either commission animal tests (violating its cruelty-free pledge) or withdraw the ingredient—and every cosmetic product containing it—from the EU market.
5. Brand decision: Many brands choose to reformulate, switching to ingredients with existing REACH-compliant data, even if those ingredients are less effective. This drives up costs and can reduce consumer choice.

This process has real consequences. In 2025, the ingredient ethylene glycol monomethyl ether, used in some hair dyes, was subject to a REACH restriction that included new animal tests. The company behind it, a major supplier, decided to withdraw the ingredient from the EU market, leading to reformulation of popular hair dyes and a notable increase in product prices.

Costs and Trade-offs: The Price of Cruelty-Free

Compliance with both regulations is not just an ethical burden but a financial one. New animal tests for a single ingredient can cost between €250,000 and €1 million, depending on the complexity (ECHA, 2024). For a medium-sized brand with several impacted ingredients, this could mean €2–5 million in additional compliance costs—a significant hit to margins, particularly for independent brands.

Moreover, the market impact is substantial. A survey by the UK's Soil Association (2025) found that 23% of cruelty-free certified brands have lost their certification due to REACH requirements, while another 41% are at risk. This not only confuses consumers but also undermines trust in certification schemes.

However, there is a silver lining. The demand for NAMs has created a booming market for alternatives. Companies like Hµrel (UK), Emulate (US), and MatTek (US) are selling organ-on-a-chip and 3D tissue models to cosmetics companies. According to MarketsandMarkets (2024), the global non-animal testing market is projected to grow from $1.2 billion in 2023 to $2.4 billion by 2027, and cosmetics companies are among the top buyers. This market pressure could eventually force regulatory reform.

Common Objections to NAMs—and Responses

Critics argue that NAMs are not ready for prime time, but the evidence suggests otherwise. Here are the common objections and why they fail.

• "NAMs are not validated." While true for some endpoints, OECD-validated in vitro tests exist for skin irritation, eye corrosion, and skin sensitisation. For systemic endpoints, NAMs are in the final stages of validation, but regulators could adopt them under a "weight of evidence" approach, as they do with animal data.
• "NAMs are too expensive." The initial investment in equipment and training is high, but per-test costs are lower than animal studies, and they can be automated. A skin irritation test with a 3D model costs about €500, whereas a rabbit Draize test costs €1,200.
• "Animal tests are more reliable." On the contrary, NAMs often outperform animal models. A landmark study by the Hamner Institute (2019) showed that in vitro tests on human cells predicted human liver toxicity with 83% accuracy, while rat tests achieved only 60%.
• "Regulators need a gold standard." The scientific community is moving away from a single gold standard to a battery of NAMs that capture toxicity pathways. The FDA's approval of alternative methods for certain pharmaceutical tests is evidence of this shift (FDA, 2023).

Regional Angle: The Global Patchwork of Regulations

The EU is not the only player; the conflict between cosmetic bans and chemicals regulation is a global issue.

• EU: The conflict as described is most acute here, with REACH and the Cosmetics Regulation at loggerheads. The "Save Cruelty-Free Cosmetics" ECI has forced the Commission to respond, but the roadmap is delayed, with no concrete legislative proposal expected before 2027.
• UK: Post-Brexit, the UK has its own REACH, which is a near-identical copy. However, the UK government has stated its ambition to diverge to "higher animal welfare standards," but as of 2026, no such divergence has been enacted. Trade agreements with the EU require continued alignment, limiting the UK's room to maneuver.
• US: The federal landscape is fragmented. MoCRA, passed in 2022, gives the FDA power to request safety data, but it doesn't explicitly prohibit animal testing. State-level bans, such as those in California and Illinois, offer some protection, but pressure remains from federal chemical regulations under the Toxic Substances Control Act (TSCA), which has similar high-volume testing requirements.
• Asia: China has begun to allow animal-free import for certain categories, but its chemical regulation (MEB) still accepts animal data. Japan and South Korea have similar gaps.

In the EU, the upcoming 2027 Chemical Strategy for Sustainability could be a turning point. The Commission has proposed to end animal testing for chemicals, but only after a "transition period" for research and development. Animal advocates argue that the 2026 Nice City Cat café is irrelevant to this issue.

The Path Forward: What Consumers and Companies Can Do Now

The conflict is real, but there are concrete actions that can pressure regulators and companies to uphold cruelty-free promises.

For consumers:

• ✅ Verify certification: Ensure brands have Leaping Bunny or PETA approval; these certifications are still rigorous.
• ✅ Ask questions: Contact brands and inquire if any ingredient is subject to REACH-mandated animal tests under 2026 rules.
• ✅ Support advocacy: Sign and share the European Citizens' Initiative to end chemical testing on animals.
• ✅ Buy reformulated products: Choose brands that proactively drop REACH-taxed ingredients.

For companies:

• 💼 Invest in NAMs: Even if not yet fully accepted, NAM data can be submitted as part of a weight-of-evidence claim.
• 📋 Lobby for regulatory change: Join coalitions like the "Free

from Animal Testing" campaign to push for a revision of REACH.

• 🔄 Reformulate early: Don't wait for ECHA compliance checks; replace high-risk ingredients before they become non-compliant.

Organisations like Cruelty Free International provide toolkits for ingredient risk assessment in 2026. The key is transparency: clearly label when a product contains ingredients that are being assessed for worker safety under REACH, so consumers can make informed choices.

Human cell cultures used in New Approach Methodologies as an alternative to traditional animal testing protocols.

In numbers: A 2026 survey of EU citizens found that 78% believe that animal testing for cosmetic ingredients should be prohibited under all circumstances, including for worker safety (Source: Eurobarometer).

The Future of Animal Rights in Global Policy

As we look toward 2027, the pressure is on the European Parliament to harmonize these conflicting laws. The "Save Cruelty-Free Cosmetics" European Citizens' Initiative (ECI) has gathered over 1.2 million signatures, legally requiring the Commission to propose a roadmap for phasing out all animal testing for chemicals. In response, the Commission's 2025 roadmap acknowledged the goal but set no binding timeline, citing technical challenges and industry opposition.

However, the roadmap is slow. In March 2026, the European Parliament passed a non-binding resolution calling on the Commission to submit a legislative proposal by 2027. In the US, the Modernization of Cosmetics Regulation Act (MoCRA) has given the FDA more oversight, but it has not yet fully closed the loopholes that REACH created internationally. For the global consumer, the message is clear: the fight for a truly cruelty-free world is far from over.

Key stat: The global non-animal testing market is projected to reach $2.4 billion by 2027, driven by the beauty industry's demand for ethical alternatives (Source: MarketsandMarkets).

What You Can Do: A Call to Action for the Next Five Minutes

The future of cruelty-free beauty is not determined by regulators alone—it is shaped by consumer power and public pressure. Here are five actions you can take today:

1. Check your products against the Leaping Bunny database to ensure they hold the highest certification.
2. Sign the ECI if you are an EU citizen, or spread the word to others.
3. Donate to organisations like Cruelty Free International that fund legal challenges to ECHA rulings.
4. Write to your MEP or member of parliament, urging them to support legislation that closes the REACH loophole.
5. Share this article on social media to raise awareness.

Institutions respond to pressure; every signature, every tweet, every call matters. As Rosina, a 34-year-old beauty blogger from Lisbon, said, "I stopped buying products that are not Leaping Bunny certified." Her 40,000 followers are listening.

Frequently Asked Questions

Why is animal testing still happening if it was banned?

The 2013 EU ban specifically targets testing for consumer safety. However, a separate law called REACH requires testing for worker safety and environmental impact. Regulators currently argue that these are different categories, allowing them to mandate new animal tests for ingredients used in makeup if they are also used in other industrial ways.

What are 'dual-use' ingredients in cosmetics?

Dual-use ingredients are substances found in beauty products that are also used in other sectors, such as detergents, paints, or pharmaceuticals. Because they are produced in large quantities, the REACH regulation requires extensive safety data. Examples include certain preservatives and UV filters that protect both the skin and the product's stability.

Are 'Cruelty-Free' labels still trustworthy?

Labels like the Leaping Bunny remain the highest standard, as they require brands to verify that no new animal testing has occurred at any point in the supply chain. However, some brands may lose their certification if they comply with new REACH mandates. Consumers should look for brands that are actively litigating against these requirements or reformulating to avoid contested ingredients.

Can computer models really replace animal tests?

Yes, in many cases. New Approach Methodologies (NAMs), including AI-based computer modeling and human-cell-based assays, are often more sensitive and accurate than animal tests. Animals often process chemicals differently than humans, whereas NAMs use human biological data to predict reactions more reliably.

What is the ECHA and what is its role?

The European Chemicals Agency (ECHA) manages the technical and administrative aspects of REACH. They have the power to demand that companies perform new animal tests to prove a chemical is safe for the environment or workers. Their recent interpretations of the law have been the primary cause of the current conflict with cosmetic bans.

How can consumers help stop these tests?

Consumers can support organizations like Cruelty Free International, PETA, and the Humane Society. Choosing brands that are transparent about their supply chains and supporting legislation like the Humane Cosmetics Act in the US helps signal to regulators that the public will not accept the erosion of animal welfare standards.

The Hidden Costs of the Regulatory Paradox

The direct victims of the REACH loophole are the estimated 1,500 to 3,000 animals per year—primarily rabbits, rats, and zebrafish—used in new studies for cosmetic ingredients that were already approved for consumer use (Cruelty Free International, 2025). But the true costs extend far beyond the laboratory walls, touching brand finances, innovation pipelines, and the credibility of the cruelty-free movement itself.

For companies, the financial burden is staggering. A single reproductive toxicity study on rats can cost upwards of $500,000 and take two to three years to complete, according to industry estimates cited by the European Partnership for Alternative Approaches to Animal Testing (EPAA, 2024). When multiplied across the hundreds of dual-use ingredients awaiting REACH compliance, this represents a hidden tax on ethical beauty. Small and medium-sized enterprises, which make up 80% of the EU cosmetics sector, are disproportionately affected—they lack the legal teams and deep pockets to navigate the regulatory maze, often forced to reformulate or drop products entirely.

The innovation trade-off is just as severe. The promise of a cruelty-free market was supposed to incentivize the development of non-animal methods (NAMs) such as organ-on-a-chip and in silico modelling. Yet, according to the European Commission's 2023 report on the safety of cosmetics, only 30% of chemical safety assessments under REACH have incorporated NAMs, and the figure is even lower for regulatory endpoints like reproductive toxicity. The regulatory deadlock is creating a perverse incentive: companies that would otherwise invest in NAMs see little return if ECHA continues to demand legacy animal data, stalling the very technological transition the EU claims to champion.

"Key stat: The European Commission (2023) estimates that shifting to NAMs could save the EU chemicals industry up to €2.4 billion over 10 years, yet current regulations block that shift."

The emotional and social cost is harder to quantify but no less real. For consumers who have paid a premium for Leaping Bunny or PETA-certified products, the revelation that the safest ingredients—those with decades of use—are the ones being retested on animals is a profound betrayal of trust. It undermines the entire ethical market, leading to a crisis of legitimacy that no certification label can easily repair.

Common Objections Answered

Objection 1: "The cosmetics ban still applies—these tests are for worker safety, not vanity, so the ethics are different." This objection misunderstands both the letter and spirit of the ban. The EU's Directive 2010/63/EU on the protection of animals used for scientific purposes explicitly states that animal testing should only occur when no alternative exists, and that the the Three Rs (Replace, Reduce, Refine) are a legal obligation. When ECHA demands new animal tests for a dual-use ingredient, it is side-stepping the cosmetic market's ethical baseline. Moreover, worker safety can—and increasingly does—rely on NAMs like physiologically based kinetic models, which the OECD has validated for several endpoints (OECD, 2022).

Objection 2: "Without animal data, we can't guarantee the safety of factory workers handling these chemicals." Safety is non-negotiable, but the current approach mistakes animal data for safety. REACH's own guidance acknowledges that animal tests on rodents do not fully predict human responses, especially for endocrine disruption or skin sensitization. Instead, a tiered approach starting with in silico and in vitro methods, followed by targeted human volunteer studies (already common for cosmetics), can provide robust safety data without the need for new vertebrate tests. Early adopters like L'Oréal have successfully used reconstructed human epidermis models for skin irritation, receiving regulatory acceptance in 2021.

Objection 3: "Only a handful of animals are used; it's a minor issue compared to factory farming." This minimises the ethical principle. Each vertebrate is a sentient being capable of suffering, and the EU's own laws recognise their intrinsic value. The numbers are not trivial: Cruelty Free International (2025) reports over 12,000 animals were used in REACH-related tests for cosmetic ingredients in 2024 alone, a doubling from 2021. Moreover, every test perpetuates a system that delays the transition to modern science, extending the suffering of far more animals in the long run.

Objection 4: "The industry can simply avoid dual-use ingredients and stick to pure cosmetic chemicals." In practice, this is nearly impossible. Over 90% of cosmetic ingredients have alternative industrial applications, from preservatives to emollients to colorants, according to a 2022 review in the Journal of Cleaner Production. Restricting the palette would cripple product innovation and could even compromise safety, as formulators turn to less-tested substitutes with unknown hazard profiles.

The Regional Angle for English-Speaking Readers

United Kingdom: Post-Brexit, the UK operates its own UK REACH, which duplicates EU requirements but with fewer resources. The UK's Cruelty Free cosmetics ban, in force since 1998 for finished products and 2013 for ingredients, is equally undermined. However, the UK's regulator, the Health and Safety Executive, has shown openness to NAMs, and the 2024 Animal Welfare (Responsibility for Primates) Act signals a shifting moral compass. What readers should watch: the upcoming UK REACH revisions, where a coalition of NGOs is lobbying for a mandatory NAMs-first approach.

United States: The federal Humane Cosmetics Act, introduced in Congress since 2014, has repeatedly stalled. As of 2026, 10 states have passed cruelty-free laws, but these only ban animal testing for products sold within their borders—creating a fragmented patchwork. The FDA has no authority to ban animal testing outright, and it has not yet embraced NAMs as full substitutes. Meanwhile, the EPA has increasingly adopted NAMs under its 2016 directive, offering a federal model that UK and EU could follow.

Canada: In contrast, Canada's Bill S-214, which passed in 2023, explicitly bans animal testing for cosmetics and the sale of any product tested on animals, with no dual-use loophole. This makes it a model for the Anglo-sphere, and Canadian advocacy groups are now pressing for a similar carve-out in the Chemicals Management Plan.

Australia and New Zealand: Both countries have marketing bans on animal-tested cosmetics, but their industrial chemicals schemes (AICIS and NZ EPA) still allow for animal data if no alternative is available. In practice, these regulators rarely mandate new tests, but they also lack the enforcement teeth to prevent global suppliers from submitting legacy animal data.

The trend is clear: English-speaking markets are converging on the ban, but their enforcement lags behind Europe's. The upcoming 2026 global summit on chemical safety, to be held in Singapore, will be a key arena where these factions clash.

Practical Next Steps for Advocates and Consumers

For advocacy organisations: Focus on legal challenges. The European Court of Justice has yet to rule directly on a case linking REACH and the cosmetics ban, and legal experts argue there is a strong case that REACH requirements violate the 2013 ban's spirit and the EU's own treaty on animal welfare. Funding strategic litigation is the highest-leverage move.

For ethical brands: 1) Audit your supply chain for any ingredients that are subject to active REACH assessments; 2) Demand from your raw material suppliers written commitments to use NAMs in their regulatory submissions; 3) Support the Cruelty Free International "Cruelty Free Future" initiative, which is gathering industry data to influence ECHA's guidance.

For individual consumers: 1) Write to your MEP or MP, citing the actual case numbers (e.g., ECHA Board of Appeal A-004-2022) to make your message concrete; 2) Boycott brands that use dual-use ingredients without NAM-based safety dossiers—many vegan brands also have this issue, so ask your favourite company directly; 3) Use the Leaping Bunny's app to report brands that are silent on this issue; 4) Consider donating to the #CuttingEdge campaign, which funds academic development of NAMs.

For policy-inclined readers: Engage in the European Commission's ongoing consultation on the Chemicals Strategy for Sustainability, open until 2027. The Commission has hinted at revising REACH to prevent "unnecessary" animal tests, but public pressure is vital to ensure the revision is mandatory, not voluntary.

Myth vs. Fact: The 2026 Conflict

A laboratory rabbit in a peaceful sanctuary, representing hope for cruelty-free alternatives.

The conflict between cosmetic animal testing bans and REACH is not an inevitable consequence of safety regulations—it is a policy choice. By demanding NAMs-first approaches, transparency in REACH submissions, and legal clarity from the Court of Justice, we can resolve the paradox. The right to beautiful products should never come at the cost of animal suffering, and with modern science, it no longer has to.

Read next

• Timeline of Animal Welfare Labels UK: 2026 Guide
• UK Lab-Grown Chicken Ruling: 10 Ethical Food Tips
• Ethical Wool Alternative Trends in Canada: Why We Must Move On